AstraZeneca PLC is 183.2x more valuable than Syndax Pharmaceuticals Inc by market capitalization ($286.27 B vs $1.56 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SNDX | AZN |
|---|---|---|
| Market cap | $1.56 B | $286.27 B |
| US-listed rank | #2297 | #45 |
| Revenue (latest FY) | $172.35M | - |
| Net income (latest FY) | -$285.40M | - |
| Net margin | -165.6% | - |
| SEC filings | 636 | 1,004 |
AstraZeneca PLC is 183.2x more valuable than Syndax Pharmaceuticals Inc by market capitalization ($286.27 B vs $1.56 B).
Full pages: Syndax Pharmaceuticals Inc and AstraZeneca PLC, or browse the full rankings.